$PAPA
Papa Medical Inc.
CIK:0002024283|SEC Filings
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|||
| Income Statement [Abstract] | ||||||
| Revenues | $ 7,368,220 | $ 9,972,437 | $ 39,948,742 | $ 27,282,305 | ||
| Cost of revenues | (5,948,565) | (7,533,271) | (30,897,167) | (20,519,407) | ||
| Gross profit | 1,419,655 | 2,439,166 | 9,051,575 | 6,762,898 | ||
| Operating expenses: | ||||||
| Selling and marketing | (1,625,511) | (1,201,905) | (5,272,330) | (3,282,642) | ||
| General and administrative | (749,573) | (599,785) | (2,206,355) | (1,483,142) | ||
| Research and development | (329,505) | (195,790) | (955,498) | (511,155) | ||
| Total operating expenses | (2,704,589) | (1,997,480) | (8,434,183) | (5,276,939) | ||
| Operating income | (1,284,934) | 441,686 | 617,392 | 1,485,959 | ||
| Interest income, net | 54 | (14,036) | 118,389 | 30,346 | ||
| Other loss, net | 987 | (7,235) | (48,801) | (111,763) | ||
| Income before income taxes | (1,283,893) | 420,415 | 686,980 | 1,404,542 | ||
| Income tax credit/(expense) | 463,970 | (115,944) | (96,626) | (356,187) | ||
| Net income attributable to the Company’s shareholders | $ (819,923) | $ 304,471 | $ 590,354 | $ 1,048,355 | ||
| Basic and diluted income per share | ||||||
| Net income per share - Basic | $ (0.04) | $ 0.02 | $ 0.03 | $ 0.05 | ||
| Net income per share - Diluted | $ (0.04) | $ 0.02 | $ 0.03 | $ 0.05 | ||
| Weighted average shares used in calculating net income per share | ||||||
| Weighted average shares used in calculating net income per share - Basic | [1] | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | |
| Weighted average shares used in calculating net income per share - Diluted | [1] | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | |
| ||||||